Ann: Positive FDA Pre-IND meeting guides IHL-42X development, page-24

I tend to agree, and every new milestone, including today's, increases the chance of concrete bids showing up for licensing, acquisition or take-over.

Although the FDA preliminary nod today is a huge step towards making this colossal drug candidate a reality to Big Pharma, we still need the full proof of concept trial results coming in June, before actionable offers might come in.

If a ResMed for instance, cannot find fault with the published results in June AND knows the FDA is greasing the fast track for pivotal trials... there is no way they can ignore IHL-42x unless each and every one of their executives are asleep at the wheel.

I'm thrilled for Incannex, and for each and every one of us. Congratulations to all those who held strong through the recent turbulence. If you are taking the long approach, the horizon is looking mighty fine.